[
    [
        {
            "time": "2018-11-29",
            "original_text": "Brokerages Target Small 401(k) Clients",
            "features": {
                "keywords": [
                    "Brokerages",
                    "Target",
                    "Small",
                    "401(k)",
                    "Clients"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "finance"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Brokerages Target Small 401(k) Clients",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-12-01",
            "original_text": "Deal or no deal? What to expect from Trump meeting with Xi Jinping",
            "features": {
                "keywords": [
                    "Deal",
                    "Trump",
                    "Xi",
                    "Jinping"
                ],
                "sentiment_score": -0.3,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "global trade"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Deal or no deal? What to expect from Trump meeting with Xi Jinping",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-12-02",
            "original_text": "Goldman Sachs, Morgan Stanley top picks to lead Swedish buyout firm EQT's IPO - sources",
            "features": {
                "keywords": [
                    "Goldman",
                    "Sachs",
                    "Morgan",
                    "Stanley",
                    "EQT",
                    "IPO"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "finance",
                    "investments"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Goldman Sachs, Morgan Stanley top picks to lead Swedish buyout firm EQT's IPO - sources",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-12-03",
            "original_text": "Goldman Sachs, Morgan Stanley top picks to lead Swedish buyout firm EQT's IPO -sources",
            "features": {
                "keywords": [
                    "Goldman",
                    "Sachs",
                    "Morgan",
                    "Stanley",
                    "EQT",
                    "IPO"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "finance",
                    "investments"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Goldman Sachs, Morgan Stanley top picks to lead Swedish buyout firm EQT's IPO -sources",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-11-30",
            "original_text": "Stifel Financial Corporation (SF) Ex-Dividend Date Scheduled for November 30, 2018",
            "features": {
                "keywords": [
                    "Stifel",
                    "Financial",
                    "Corporation",
                    "Ex-Dividend",
                    "Date"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "finance"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Stifel Financial Corporation (SF) Ex-Dividend Date Scheduled for November 30, 2018",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 3,
                "Headline_Structure": 5,
                "Source_Recency": 2
            }
        },
        {
            "time": "2018-12-04",
            "original_text": "WuXi AppTec to List in Hong Kong",
            "features": {
                "keywords": [
                    "WuXi",
                    "AppTec",
                    "List",
                    "Hong",
                    "Kong"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "WuXi AppTec to List in Hong Kong",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-12-05",
            "original_text": "The Black Swan That Could Sink Celgene",
            "features": {
                "keywords": [
                    "Black",
                    "Swan",
                    "Celgene"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "The Black Swan That Could Sink Celgene",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]